首页> 外国专利> USE OF A PROTEIN/PEPTIDE COMPLEX FOR TREATING AND PREVENTING ATHEROSCLEROSIS, METHOD FOR TREATING AND PREVENTING ATHEROSCLEROSIS (VARIANTS)

USE OF A PROTEIN/PEPTIDE COMPLEX FOR TREATING AND PREVENTING ATHEROSCLEROSIS, METHOD FOR TREATING AND PREVENTING ATHEROSCLEROSIS (VARIANTS)

机译:蛋白质/肽复合物在治疗和预防动脉粥样硬化中的用途,治疗和预防动脉粥样硬化的方法(变体)

摘要

The invention relates to medicine and pharmacology, and more particularly to a method for treating and preventing atherosclerosis of major vessels (of the brain, heart and lower limbs) and the aorta using a pharmaceutical agent which contains a therapeutic protein/peptide preparation. The present method comprises administering parenterally or intranasally to a patient a therapeutic preparation in combination with a pharmaceutically acceptable carrier. The therapeutic preparation includes a protein/peptide complex obtained from embryonic brain tissue of cattle and contains negatively charged and neutral proteins and polypeptides with an average molecular mass of from 5 to 200 kDa. The pharmaceutical preparation may additionally contain an immunomodulatory and stimulatory component in the form of hydrolyzed polynucleotides in the form of Na salts of DNA obtained from the milt of sturgeon or salmon. As pharmaceutically acceptable carrier, the preparation contains a diluent, including a saline or buffered saline solution, and possibly various adjuvants. Depending on the severity of the illness (atherosclerosis, site of vessel damage), the preparation is administered subcutaneously, intramuscularly, intravenously, by slow bolus or intranasally in different cycles with the preparation containing 0.01-0.7 mg of protein/peptide complex or protein/peptide/polynucleotide complex in a physiologically acceptable carrier, for example a diluent. The invention provides for reverse cholesterol transport and increases the effectiveness of atherosclerosis treatment and prevention.
机译:本发明涉及医学和药理学,更具体地涉及一种使用包含治疗性蛋白质/肽制剂的药剂来治疗和预防(大脑,心脏和下肢的)主要血管和主动脉的动脉粥样硬化的方法。本方法包括将与药学上可接受的载体组合的治疗制剂肠胃外或鼻内给予患者。该治疗制剂包括从牛的胚胎脑组织获得的蛋白质/肽复合物,并包含带负电荷的中性蛋白质和平均分子量为5至200 kDa的多肽。所述药物制剂可以另外包含水解多核苷酸形式的免疫调节和刺激成分,所述水解多核苷酸形式是从from鱼或鲑鱼的salmon鱼获得的DNA的Na盐形式。作为药学上可接受的载体,该制剂包含稀释剂,包括盐溶液或缓冲盐溶液,以及可能的各种佐剂。根据疾病的严重程度(动脉粥样硬化,血管损伤部位),可通过皮下注射,肌肉注射,静脉内注射,缓慢推注或鼻内给药在不同的周期内使用含有0.01-0.7 mg蛋白质/肽复合物或蛋白质/生理上可接受的载体,例如稀释剂中的肽/多核苷酸复合物。本发明提供胆固醇的逆向转运并增加动脉粥样硬化治疗和预防的有效性。

著录项

  • 公开/公告号EP3207939A4

    专利类型

  • 公开/公告日2018-07-11

    原文格式PDF

  • 申请/专利权人 DIAMONDZLITE LIMITED;NAZARENKO ANNA BORISOVNA;

    申请/专利号EP20150850491

  • 发明设计人 NAZARENKO ANNA BORISOVNA;

    申请日2015-09-15

  • 分类号A61K35/30;A61K35/545;A61K35/60;A61K38/02;A61K38/17;A61P9/10;

  • 国家 EP

  • 入库时间 2022-08-21 13:19:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号